Paul C. Francis - Concepedia

Author

Paul C. Francis

Also Known As

P C Francis, P FRANCIS, P. C. Francis, P. Francis, P.C. Francis, P.T. Francis, Paul C Francis, Paul C. Francis, Paul Francis

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Kentucky The Ohio State University

About

Paul C. Francis is an author at Eli Lilly (United States) specializing in medicine, endocrinology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	903
2	Public Health	4	4	75
3	Health Sciences	2	2	702
4	Engineering	1	1	16
5	Biology	1	1	33

Paul C. Francis

Publications

Citations

H-Index

Page 1

	Year	Citations
Skeletal Changes in Rats Given Daily Subcutaneous Injections of Recombinant Human Parathyroid Hormone (1-34) for 2 Years and Relevance to Human Safety John L. Vahle, Masahiko Sato, Gerald G. Long, Toxicologic Pathology Subcutaneous InjectionsParathyroid DiseasePathologyParathyroid GlandOrthopaedic Surgery	2002	691
Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator Gerald G. Long, Ilene R. Cohen, Christian L. Gries, Toxicologic Pathology	2001	43
Ecology of deepwater rice-fields in Bangladesh 1. Physical and chemical environment B. A. Whitton, Paul C. Francis, Joachim Röther, Hydrobiologia Chemical EnvironmentDeepwater Rice-fieldsCrop EcologyWater QualityLand Degradation	1988	35
Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator Gerald G. Long, Ilene R. Cohen, Christian L. Gries, Toxicologic Pathology Hormonal ContraceptiveFertilityProliferative LesionsGynecologyFemale Reproductive Function	2001	34
Effects of cadmium-enriched sediment on fish and amphibian embryo-larval stages Paul C. Francis, Wesley J. Birge, Jeffrey A. Black Ecotoxicology and Environmental Safety BiologyCadmium-enriched SedimentBiomagnificationDevelopmental BiologySediment Quality	1984	33
Integrated analysis of preclinical data to support the design of the first in man study of LY2181308, a second generation antisense oligonucleotide Sophie Callies, Valérie André, Bharvin K.R. Patel, British Journal of Clinical Pharmacology	2010	29
The Selective Estrogen Receptor Modulator, Raloxifene: A Segment II/III Delivery Study in Rats 11This study (except for immune system assessments) was conducted in accordance with the FDA’s Good Laboratory Practices for Nonclinical Laboratory Studies [1]. Judy Buelke‐Sam, Ilene R. Cohen, Daniel Wierda, Reproductive Toxicology Molecular PharmacologyImmune System AssessmentsMedicineHormonal ReceptorUterine Receptivity	1998	24
Oncogenicity study of trifluralin in B6C3F1 mice Paul C. Francis, John L. Emmerson, Elizabeth R. Adams, Food and Chemical Toxicology InflammationOncogenic AgentImmunologyOncogenicity StudyMedicine	1991	19
The Selective Estrogen Receptor Modulator, Raloxifene: Segment II Studies in Rats and Rabbits 11These studies were conducted in accordance with the Food and Drug Administration “Good Laboratory Practice Regulations for Nonclinical Laboratory Studies” [1]. Richard A. Byrd, Paul C. Francis Reproductive Toxicology Molecular PharmacologySegment Ii StudiesMedicineHormonal ReceptorGynecology	1998	17
Chronic toxicity of 4-nitrophenol toDaphnia magna straus under statis-renewal and flow-through conditions Paul C. Francis, Douglas W. Grothe, John C. Scheuring Bulletin of Environmental Contamination and Toxicology EcotoxicityEnvironmental EngineeringChronic ToxicityFlow-through ConditionsMedicine	1986	17

Page 1